RECURRENCE OF CHCV AFTER THE USE OF DIRECT ANTIVIRAL DRUGS: CLINICS, DIAGNOSIS, TREATMENT AND OUTCOMES

Authors

  • Jurayev J.S., Termez branch of the Tashkent Medical Academy
  • Karshiev.M.A Infectious diseases hospital of Surkhandarya region
  • Uralov A.A 5th year student of the Termez branch of the Tashkent Medical Academy

Keywords:

extrahepatic manifestations, relapse, IFN + riboverine, retreatment of relapse HCV RNA genotype 1b.

Abstract

Viral hepatitis C is one of the leading liver diseases. According to
WHO, 70 million people are infected with this disease. HCV kills 290,000 people
every year. In 95% of patients, the disease becomes chronic, and the main
complications are fibrosis and cirrhosis of the liver. In some cases, a relapse is
observed, despite treatment with antiviral drugs.

References

Kuznetsov N.I., Romanova E.S., Startseva G.Yu. Modern principles of antiviral

therapy for hepatitis C. // Russian Family Physician, Moscow 2018; 23-28. 2.

Musabaev I.K., Musabaev E.I., Atabekov N.S. Hepatitis C: etiology,

epidemiology, pathogenesis, clinical picture, differential diagnosis, therapy and

prevention. – / Tashkent, 2000; 32-37.

Khubutia M.Sh., Syutkin V.E., Zhuravel S.V., Novruzbekov M.S., Fedin A.B.

The use of sobosfuvir for the treatment of hepatitis C after liver transplantation. //

Clinical Medicine, Moscow 2017; 78-84

Downloads

Published

2024-05-12

Issue

Vol. 1 No. 4 (2024): INTERNATIONAL CONFERENCE ON MEDICINE, SCIENCE, AND EDUCATION

Section

Articles

How to Cite

RECURRENCE OF CHCV AFTER THE USE OF DIRECT ANTIVIRAL DRUGS: CLINICS, DIAGNOSIS, TREATMENT AND OUTCOMES. (2024). INTERNATIONAL CONFERENCE ON MEDICINE, SCIENCE, AND EDUCATION, 1(4), 98-99. https://universalconference.us/universalconference/index.php/icmse/article/view/1301